Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Shveta Gupta, MD
Arnold Palmer Hospital for Children
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospital Centre Zagreb
Zagreb, Croatia
Recruiting
- Helsinki University Hospital
Helsinki, Finland
Recruiting
- Chu de Nantes Hôtel-Dieu
Nantes, France
Recruiting - Chru de Tours
Tours, France
Recruiting
- Vivantes Klinikum Im Friedrichshein (kfh)
Berlin, Germany
Recruiting - Gerinnungszentrum Rhein-Ruhr
Duisburg, Germany
Recruiting - Universitätsklinikum Hamburg Eppendorf (uke)
Hamburg, Germany
Recruiting
- Christian Medical College Vellore
Vellore, Tamil Nadu, India
Recruiting - St. John'S Medical College Hospital
Bengaluru, India
Recruiting
- Azienda Ospedaliera Pugliese Ciaccio
Catanzaro, Italy
Recruiting - Azienda Ospedaliero Universitaria Careggi - Centro Emofilia
Florence, Italy
Recruiting - Centro Trombosi E Malattie Emorragiche, Itccs Humanitas Research Hospital
Milan, Italy
Recruiting
- Centre for Haemopilia, Institute for Transfusion Medicine of Republic of North Macedonia
Skopje, North Macedonia
Recruiting
- Clinical Center for Serbia Belgrade
Belgrade, Serbia
Recruiting
- Hospital Universitario la Paz
Madrid, Spain
Recruiting - Hospital Universitario Virgen del Rocio
Seville, Spain
Recruiting
- St. James'S University Hospital
Leeds, United Kingdom
Not, yet, recruiting
- Ut Southwestern Medical Center
Dallas, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Nov 2023
- Primary completion
- 31 Aug 2026
- Completion
- 30 Sept 2026
- Last update posted
- 12 May 2026
- Registered enrollment
- 28
- Registry id
- NCT05935358
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.